Researchers at LMU have developed a human cell model that replicates key mechanisms of neurodegenerative diseases—with ...

Patients with operable non-small cell lung cancer (NSCLC) had significantly longer event-free survival (EFS) with ...

Can weight-loss drugs like semaglutide prevent Alzheimer's? New research reveals GLP-1 drugs reduce amyloid and tau proteins ...

Unite have announced that workers are ramping up their strike action at Barking, Havering and Redbridge University Hospitals ...

STROKE trial show a 26% reduction in recurrent stroke with the factor XIa inhibitor asundexian, with no increased bleeding ...

StatLab Medical Products, a leading developer and manufacturer of pathology supplies and equipment, today announced it has ...

Results consistent with pre-clinical studies demonstrating that, in the early stages of the neurodegenerative process, ...

Presentation reinforces ATH434's clinical profile ahead of Phase 3 engagement with regulators - MELBOURNE, Australia and SAN FRANCISCO, April 22, 2026 (GLOBE NEWSWIRE)-- Alterity Therapeutics (ASX: ...

An AI model applied to pathology slides accurately predicts immunotherapy response in patients with metastatic non-small cell ...

Mortuary services could be moved to a hospital trust under plans The Black Country's last council-run mortuary could shut ...

The company claims the tool can compress a task that typically takes around 30 minutes into a few minutes, based on early ...

A phase 2 study evaluated the efficacy and safety of adding pembrolizumab to trimodal therapy as a bladder-sparing approach for muscle-invasive bladder cancer (MIBC).